FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
SAN FRANCISCO, CA USA (UroToday.com) - Presented by Dean F. Bajorin, Padmanee Sharma, Leonard G. Gomella, Elizabeth R. Plimack, Peter H. O'Donnell, Jean H. Hoffman-Censits, Thomas W. Flaig, David I. Quinn, Robert Brownell Sims, Michael Locker, Nadeem A. Sheikh, Todd DeVries, and Seth P. Lerner at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
Memorial Sloan-Kettering Cancer Center, New York, NY; The University of Texas MD Anderson Cancer Center, Houston, TX; Jefferson Medical College and Kimmel Cancer Center, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA; The University of Chicago, Chicago, IL; University of Colorado, Denver, CO; USC Norris Comprehensive Cancer Center, Los Angeles, CA; Dendreon Corporation, Seattle, WA; Baylor College of Medicine, Houston, TX